Shanghai HeartCare Medical Technology Co., Ltd.

Shanghai HeartCare Medical Technology Co., Ltd. (Stock Code: 06609.HK), established in 2016, focuses on addressing the unmet needs of clinical practitioners and patients in China. The company is committed to enhancing the accessibility of innovative medical technologies and products, reducing mortality rates from major diseases, improving patient outcomes, and safeguarding life and health. Headquartered in the Lingang New Area of Shanghai, HeartCare also operates R&D and manufacturing centers, Nanjing Jiangbei New Area, and California, USA, with additional branches in Beijing, Hong Kong, and other locations.

Currently, HeartCare has pioneered a comprehensive one-stop solution for the treatment and prevention of stroke within the neuro-interventional field. Its product pipeline includes neuro-interventional devices for thrombectomy, aneurysms, and stenosis, as well as interventional access devices and stroke prevention devices. The company holds 31 domestic medical device registration certificates, has been granted over 200 patents, and has two products qualified for “Priority Review of Innovative Devices.” we have established an extensive distribution network covering over 2,500 hospitals across all provinces nationwide other than Hong Kong and Macau.